CARLISI, Melania
 Distribuzione geografica
Continente #
NA - Nord America 2.805
EU - Europa 1.376
AS - Asia 1.145
SA - Sud America 213
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.582
Nazione #
US - Stati Uniti d'America 2.772
SG - Singapore 485
IT - Italia 426
RU - Federazione Russa 426
CN - Cina 275
BR - Brasile 168
DE - Germania 119
HK - Hong Kong 114
VN - Vietnam 95
PL - Polonia 86
FR - Francia 66
FI - Finlandia 64
GB - Regno Unito 62
JP - Giappone 27
IE - Irlanda 26
IN - India 23
BD - Bangladesh 22
AR - Argentina 20
IQ - Iraq 16
BE - Belgio 15
ES - Italia 13
UA - Ucraina 13
UZ - Uzbekistan 13
SE - Svezia 12
TR - Turchia 12
CA - Canada 11
KR - Corea 11
NL - Olanda 10
RO - Romania 10
ZA - Sudafrica 10
AT - Austria 9
EG - Egitto 9
MX - Messico 9
JO - Giordania 7
CL - Cile 6
MA - Marocco 6
PK - Pakistan 6
VE - Venezuela 6
IR - Iran 5
HN - Honduras 4
ID - Indonesia 4
NP - Nepal 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
CI - Costa d'Avorio 3
CO - Colombia 3
CR - Costa Rica 3
DK - Danimarca 3
EC - Ecuador 3
IL - Israele 3
LT - Lituania 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
CH - Svizzera 2
DZ - Algeria 2
GR - Grecia 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
MY - Malesia 2
SN - Senegal 2
TH - Thailandia 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.582
Città #
Ashburn 422
Fairfield 345
Singapore 303
Chandler 191
Woodbridge 145
San Jose 141
Houston 126
Wilmington 118
Cambridge 114
Palermo 111
Seattle 110
Ann Arbor 106
Hong Kong 106
Zgierz 75
Council Bluffs 74
Moscow 68
Beijing 62
Des Moines 50
Helsinki 49
Dallas 42
Los Angeles 42
New York 39
Lauterbourg 38
Medford 38
Hanoi 32
Altamura 29
Boardman 29
Milan 29
Hefei 27
Dublin 26
Tokyo 25
Ho Chi Minh City 24
Princeton 24
Lawrence 21
Bremen 20
Santa Clara 20
São Paulo 20
The Dalles 20
Rome 19
Chicago 16
Nanjing 16
San Diego 16
Buffalo 15
Frankfurt am Main 15
Ludwigshafen am Rhein 15
Brussels 14
London 14
Piscataway 14
Tashkent 13
Lappeenranta 12
Orem 12
Shenyang 12
Munich 11
Nuremberg 10
Warsaw 10
Washington 10
Brooklyn 9
Denver 9
Columbus 8
Redondo Beach 8
Amman 7
Cairo 7
Dearborn 7
Salt Lake City 7
Turin 7
Catania 6
Ningbo 6
Redwood City 6
Santo André 6
Torino 6
Chennai 5
Da Nang 5
Düsseldorf 5
Guangzhou 5
Mexico City 5
Naples 5
Phoenix 5
Poplar 5
Portsmouth 5
Shanghai 5
Venice 5
Vicenza 5
Ankara 4
Bến Tre 4
Cagliari 4
Central 4
Hebei 4
Jiaxing 4
Jinan 4
Johannesburg 4
Madrid 4
San Francisco 4
Santiago 4
Tianjin 4
Zhengzhou 4
Abidjan 3
Amsterdam 3
Atlanta 3
Bad Dürrenberg 3
Bari 3
Totale 3.731
Nome #
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study 326
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 300
Aspetti emoreologici nella iperviscosità policitemica e sierica 271
Erythrocyte deformability and hemorheological profile in multiple myeloma 229
Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma 228
Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS) 224
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis 211
Immunosenescence and lymphomagenesis 211
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 209
Clinical disorders responsible for plasma hyperviscosity and skin complications 201
Cardio-oncology in multiple myeloma: is it time for a specific focus? 191
Evaluation of Bone Marrow CD8+ tissue-Resident Memory T Cells in Multiple Myeloma 191
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again 179
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 169
Red blood cell deformability in multiple myeloma 167
Lymphomas and thyroid: Bridging the gap 163
EVALUATION AND POTENTIAL ROLE OF BONE MARROW TISSUE-RESIDENT MEMORY T-CELLS IN PATIENTS WITH PLASMA CELL DYSCRASIAS 155
The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma 147
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 140
Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype 138
Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders 131
An assessment of the hemorheological profile in patients with subclinical carotid atherosclerosis divided in relation to the number of cardiovascular risk factors and different degrees of insulin resistance 127
Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs 124
Network meta-analysis of randomized trials in multiple myeloma efficacy and safety in frontline therapy for patients not eligible for transplant 124
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations 118
Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps 103
Erythrocyte deformability profile evaluated by laser diffractometry in patients with multiple myeloma: Re-examination of our cases 95
Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors 93
Leukocyte subtypes, gelatinases, and their tissue inhibitors in a group of subjects with asymptomatic carotid atherosclerosis 91
Red Cell Distribution Width and Elongation Index in a Cohort of Patients With Juvenile Acute Myocardial Infarction 90
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma 87
Uric acid and uric acid/creatinine ratio and their correlations with the hemorheological determinants in subjects with subclinical carotid atherosclerosis 85
Calculated haemorheological profile and laboratory parameters in new diagnosed multiple myeloma patients: retrospective analysis according to survival 81
Polymorphonuclear phenotypical expression of CD18, at baseline and after in vitro activation, in several clinical disorders: Revision of our case series 78
Calculated whole blood viscosity in non-diabetic subjects with asymptomatic carotid atherosclerosis: How insulin resistance may affect blood viscosity 78
Reflections on the unexpected laboratory finding of hemorheological alterations observed in some haematological disorders 69
Neutrophil/HDL-C, Lymphocyte/HDL-C and Monocyte/HDL-C in subjects with asymptomatic carotid atherosclerosis 66
Thrombotic Risk and Calculated Whole Blood Viscosity in a Cohort of Patients With New Diagnosis of Multiple Myeloma 51
Red Blood Cell Distribution Width, Erythrocyte Indices, and Elongation Index at Baseline in a Group of Trained Subjects 48
Prognostic potential of albumin to fibrinogen ratio in multiple myeloma patients 22
Totale 5.811
Categoria #
all - tutte 22.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.087


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 0 0 34
2021/2022299 15 36 11 17 8 14 23 20 35 50 19 51
2022/2023613 52 98 9 76 70 85 53 49 61 17 37 6
2023/2024406 16 56 37 58 28 55 34 28 5 7 27 55
2024/2025731 24 41 27 70 33 28 92 58 62 73 88 135
2025/20262.280 184 114 150 165 239 370 354 246 166 175 103 14
Totale 5.811